Case Study: Nitrosamine Risk Assessment and Confirmatory LC-MS/MS Testing for a Metformin Generic
The Critical Role of Nitrosamine Testing for a Metformin Generic Nitrosamine Testing for a Metformin Generic is a critical regulatory […]
What Is the Difference Between a Nitrosamine Impurity and a Nitrosamine Leachable?
Process vs. Material Origins Nitrosamine impurities originate from active pharmaceutical ingredient (API) synthetic pathways, degraded raw materials, or chemical interactions
What Is the Difference Between a Nitrosamine Impurity and a Nitrosamine Leachable? Read More »
Do All Drug Products Need a Nitrosamine Risk Assessment? FDA’s Risk-Based Approach Explained
Assessing the chemical safety of human drug products requires a thorough understanding of potential mutagenic and carcinogenic impurities that fall
What Happens When a Nitrosamine Exceeds the Acceptable Intake Limit? Steps a Sponsor Must Take
Introduction: When a nitrosamine exceeds the acceptable intake limit in a drug product or active pharmaceutical ingredient (API), it triggers
How Long Does Nitrosamine Testing Take? Realistic Timelines by Study Type
Maintaining a predictable Nitrosamine Testing Timeline has become a critical operational requirement for pharmaceutical manufacturers working to meet stringent compliance
How Long Does Nitrosamine Testing Take? Realistic Timelines by Study Type Read More »
Nitrosamine Analytical Method Development and Validation Services: From LOQ to Full GMP Validation
Introduction: Why Conventional Analytical Methods Are Insufficient for Nitrosamines For pharmaceutical manufacturers facing increasing regulatory scrutiny regarding genotoxic impurities, conventional
Nitrosamine Risk Assessment and Testing Services for NDA and BLA Submissions
Introduction: Nitrosamine impurities are among the most scrutinized safety concerns in modern pharmaceutical development, and no NDA or BLA submission
Nitrosamine Risk Assessment and Testing Services for NDA and BLA Submissions Read More »
Nitrosamine Testing for Beta-Blockers, ACE Inhibitors and Sartans: Drug-Class-Specific CRO Services
Introduction: Why a Single Nitrosamine Testing Panel Is Insufficient for Cardiac Drug Classes Understanding drug-class-specific nitrosamine chemistry is one of
Outsourcing Nitrosamine Testing to a CRO: Scope of Work, Timeline, and Cost Expectations
Introduction: Pharmaceutical manufacturers function under rigorous oversight from major global regulatory agencies, including the United States Food and Drug Administration
Outsourcing Nitrosamine Testing to a CRO: Scope of Work, Timeline, and Cost Expectations Read More »
Nitrosamine Impurities in Biologics and Biotechnology-Derived Products: Regulatory Status and Testing Approach
Introduction: The Expanding Regulatory Landscape for Nitrosamine Impurities in Biologics The nitrosamine crisis that affected the small-molecule pharmaceutical industry between